Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Graves' Orbitopathy
NCT03110848Phase 2Completed
- Sponsor
- University of Pisa
- Start
- Jun 2020
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in Graves Orbitopathy (GO), sponsored by University of Pisa. Started Jun 2020; status: completed.
02
Drugs
atorvastatin
03
Conditions
Graves Orbitopathy (GO)
Beyond the preview
Go deeper on NCT03110848.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03110848.